• Something wrong with this record ?

Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway

G. Rolová, S. Skurtveit, R. Gabrhelík, V. Mravčík, I. Odsbu

. 2024 ; 19 (1) : 37. [pub] 20240514

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc24013940

Grant support
NU20-09-00066 Ministerstvo Zdravotnictví Ceské Republiky
320360 Norges Forskningsråd
Cooperatio (HEAS) Univerzita Karlova v Praze

BACKGROUND: Knowledge of co-occurring mental disorders (termed 'dual diagnosis') among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual diagnoses in two national cohorts of OAT patients and (2) to compare mental disorders between OAT patients and the general populations stratified on sex and standardized by age. METHODS: A registry-linkage study of OAT patients from Czechia (N = 4,280) and Norway (N = 11,389) during 2010-2019 was conducted. Data on mental disorders (F00-F99; ICD-10) recorded in nationwide health registers were linked to the individuals registered in OAT. Dual diagnoses were defined as any mental disorder excluding substance use disorders (SUDs, F10-F19; ICD-10). Sex-specific age-standardized morbidity ratios (SMR) were calculated for 2019 to compare OAT patients and the general populations. RESULTS: The prevalence of dual diagnosis was 57.3% for Czechia and 78.3% for Norway. In Czechia, anxiety (31.1%) and personality disorders (25.7%) were the most prevalent, whereas anxiety (33.8%) and depression (20.8%) were the most prevalent in Norway. Large country-specific variations were observed, e.g., in ADHD (0.5% in Czechia, 15.8% in Norway), implying differences in screening and diagnostic practices. The SMR estimates for any mental disorders were 3.1 (females) and 5.1 (males) in Czechia and 5.6 (females) and 8.2 (males) in Norway. OAT females had a significantly higher prevalence of co-occurring mental disorders, whereas SMRs were higher in OAT males. In addition to opioid use disorder (OUD), other substance use disorders (SUDs) were frequently recorded in both countries. CONCLUSIONS: Results indicate an excess of mental health problems in OAT patients compared to the general population of the same sex and age in both countries, requiring appropriate clinical attention. Country-specific differences may stem from variations in diagnostics and care, reporting to registers, OAT provision, or substance use patterns.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013940
003      
CZ-PrNML
005      
20240905134113.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13722-024-00467-5 $2 doi
035    __
$a (PubMed)38741162
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Rolová, Gabriela $u Department of Addictology, First Faculty of Medicine, Charles University, Apolinářská 4, Prague, 128 00, Czechia. gabriela.rolova@lf1.cuni.cz $u Department of Addictology, General University Hospital in Prague, Prague, Czechia. gabriela.rolova@lf1.cuni.cz $1 https://orcid.org/0000000272387449
245    10
$a Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway / $c G. Rolová, S. Skurtveit, R. Gabrhelík, V. Mravčík, I. Odsbu
520    9_
$a BACKGROUND: Knowledge of co-occurring mental disorders (termed 'dual diagnosis') among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual diagnoses in two national cohorts of OAT patients and (2) to compare mental disorders between OAT patients and the general populations stratified on sex and standardized by age. METHODS: A registry-linkage study of OAT patients from Czechia (N = 4,280) and Norway (N = 11,389) during 2010-2019 was conducted. Data on mental disorders (F00-F99; ICD-10) recorded in nationwide health registers were linked to the individuals registered in OAT. Dual diagnoses were defined as any mental disorder excluding substance use disorders (SUDs, F10-F19; ICD-10). Sex-specific age-standardized morbidity ratios (SMR) were calculated for 2019 to compare OAT patients and the general populations. RESULTS: The prevalence of dual diagnosis was 57.3% for Czechia and 78.3% for Norway. In Czechia, anxiety (31.1%) and personality disorders (25.7%) were the most prevalent, whereas anxiety (33.8%) and depression (20.8%) were the most prevalent in Norway. Large country-specific variations were observed, e.g., in ADHD (0.5% in Czechia, 15.8% in Norway), implying differences in screening and diagnostic practices. The SMR estimates for any mental disorders were 3.1 (females) and 5.1 (males) in Czechia and 5.6 (females) and 8.2 (males) in Norway. OAT females had a significantly higher prevalence of co-occurring mental disorders, whereas SMRs were higher in OAT males. In addition to opioid use disorder (OUD), other substance use disorders (SUDs) were frequently recorded in both countries. CONCLUSIONS: Results indicate an excess of mental health problems in OAT patients compared to the general population of the same sex and age in both countries, requiring appropriate clinical attention. Country-specific differences may stem from variations in diagnostics and care, reporting to registers, OAT provision, or substance use patterns.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a registrace $7 D012042
650    _2
$a dospělí $7 D000328
650    _2
$a lidé středního věku $7 D008875
650    _2
$a diagnóza dvojí (psychiatrie) $7 D017831
650    12
$a poruchy spojené s užíváním opiátů $x epidemiologie $x farmakoterapie $7 D009293
650    _2
$a prevalence $7 D015995
650    12
$a opiátová substituční terapie $x statistika a číselné údaje $7 D058850
650    12
$a duševní poruchy $x epidemiologie $x farmakoterapie $7 D001523
650    _2
$a mladý dospělý $7 D055815
650    _2
$a mladiství $7 D000293
650    _2
$a opioidní analgetika $x terapeutické užití $7 D000701
650    _2
$a poruchy osobnosti $x epidemiologie $7 D010554
650    _2
$a úzkostné poruchy $x epidemiologie $x farmakoterapie $7 D001008
650    _2
$a senioři $7 D000368
650    _2
$a sexuální faktory $7 D012737
651    _2
$a Norsko $x epidemiologie $7 D009664
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Skurtveit, Svetlana $u Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway $u Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway
700    1_
$a Gabrhelík, Roman $u Department of Addictology, First Faculty of Medicine, Charles University, Apolinářská 4, Prague, 128 00, Czechia $u Department of Addictology, General University Hospital in Prague, Prague, Czechia
700    1_
$a Mravčík, Viktor $u Department of Addictology, First Faculty of Medicine, Charles University, Apolinářská 4, Prague, 128 00, Czechia $u Department of Addictology, General University Hospital in Prague, Prague, Czechia
700    1_
$a Odsbu, Ingvild $u Department of Addictology, First Faculty of Medicine, Charles University, Apolinářská 4, Prague, 128 00, Czechia $u Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
773    0_
$w MED00172344 $t Addiction science & clinical practice $x 1940-0640 $g Roč. 19, č. 1 (2024), s. 37
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38741162 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134107 $b ABA008
999    __
$a ok $b bmc $g 2143631 $s 1225806
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 19 $c 1 $d 37 $e 20240514 $i 1940-0640 $m Addiction science & clinical practice $n Addict Sci Clin Pract $x MED00172344
GRA    __
$a NU20-09-00066 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a 320360 $p Norges Forskningsråd
GRA    __
$a Cooperatio (HEAS) $p Univerzita Karlova v Praze
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Archiving options